Speakers

Anne Kjøbsted Markvardsen 

Registered nurse from Aarhus School of Nursing in 2009 and has been employed  at the Stroke  Unit at Department of Neurology, Aarhus University Hospital, since.

Anne is responsible for education of the nurses in the department regarding intravenous thrombolysis and thrombectomy. She trains the nurses in the admission process of patients with acute ischemic stroke, and has studied how organizational changes in the acute admission can reduce the door-to-needle-time. 

Annette Kjaersgaard

PhD, Hammel Neurorehabilitation Centre and University Research Clinic

I am educated as an occupational therapist in 1989 and have worked within the field of neurorehabilitation since then. In 2002 I became the first Nordic instructor in Facial-Oral Tract Therapy (F.O.T.T.) and have been teaching more than 60 ground courses in F.O.T.T. In 2013 I completed my Ph.D. thesis "Difficulties in swallowing and eating following acquired brain injury – from a professional and a patient perspective" at the Research initiative for Rehabilitation, Department of Public Health at the University of Southern Denmark, Odense, Denmark. My research profile can be summarized as clinical and practice related research with the aim to understand and explain, as well as contributing to evidence-based interdisciplinary clinical practice in neurorehabilitation. My main focus is on assessment and treatment of oropharyngeal dysphagia in patients with acquired brain injury. Today I am the head of the Competence Centre of Oropharyngeal Dysphagia, Hammel Neurorehabilitation and Research Centre, Denmark

Arne Lindgren

Professor of Neurology at Lund University and also serves as Neurology Senior Consultant at Skåne University Hospital, Lund, Sweden

Arne Lindgrens research includes Clinical studies on stroke epidemiology and risk factors, stroke genetics and outcome. In 1995 he defended his PhD thesis "Cerebrovascular disease in Lund, Southern Sweden". He became senior consultant in Neurology in 2001 and full time professor of Neurology in 2008. Arne Lindgren is PI of Lund Stroke Register, consecutively recruiting stroke patients at Skåne University Hospital, Lund. He is founding member and previous chair of the steering committee of the International Stroke Genetics Consortium (ISGC). He heads the multicenter Genetics of Ischaemic Stroke Functional Outcome (GISCOME) study, and is a co-PI of the NIH sponsored SiGN study on genetics of stroke risk. He chaired the Nordic Stroke Conference in Malmö 2015, and is member of the European Stroke Organisation and the American Stroke Association.

Birgitte Hysse Forchhammer (1960)

MA (1985) and PhD (1995) from University of Copenhagen and specialist in neuropsychology (1997)

Birgitte has pursued clinical neuropsychology for more than 25 years and has served as head of the Department of Neuropsychology at Gentofte Hospital and Rigshospitalet University Hospital since 1996. Her main research areas are cognition, neurorehabilitation and user involvement.   2009 she chaired a national working group established by the Danish Ministry of health. The purpose of the group was to produce a Medical Technology Assessment of the effects of neurorehabilitation. The Work was completed in 2011, and the conclusions has become of great importance for the future organization of neurorehabilitation in Denmark.

Bo Norrving

Professor in neurology at Lund University, Sweden

Bo Norrvings research activities have focused on stroke epidemiology, stroke syndromes, small vessel disease, ultrasound, neuroimaging, clinical genetics, clinical trials and organisation of stroke services. He has been involved in a large number of seminal clinical trials, including SALT and SIFAP. He has contributed to >400 articles in peer-reviewed medical journals. He is Editor-in-Chief of the European Stroke Journal. He is a founder and current chair of Riksstroke. He is member of the neurology advisory group for the ICD-11 at WHO. Bo Norrving has played an important leadership role in raising the profile of stroke globally. He was President of the World Stroke Organisation (WSO) from 2008 to 2012. Under his term as President, WSO underwent a phase of substantial expansion and extension of activities, including involvement with governmental bodies. 

Christopher McCabe

I am a principal investigator working on pre-clinical models of stroke at the University of Glasgow, Scotland

My research group is interested in understanding the mechanisms of brain damage during the acute phase following stroke particularly in animal models that display known stroke co-morbidities (i.e hypertension, gender, hyperglycaemia).  We are investigating novel approaches to protect the brain and vasculature following stroke with the aim of protecting the ischaemic penumbra and promoting regeneration. We use a range of in vivo research techniques such as MRI, laser Doppler flowmetry, laser speckle contrast imaging, and in vivo autoradiography as well as ex-vivo techniques such as histology, western blotting, and PCR.  I am an editorial board member for the Journal of Cerebral Blood Flow & Metabolism and joint organiser of the 30th International Society for Cerebral Blood Flow & Metabolism (ISCBF&M) conference to be held in Glasgow in 2021

Claus Ziegler Simonsen

Claus Ziegler Simonsen was educated at the medical school at Aarhus University Hospital, graduating in the year 2000. During studying, he finished a research assignment on “Stroke in the Pig”. He defended his PhD in 2002 with the title “Perfusion Imaging with Magnetic Resonance in Acute Ischemic Stroke.”

He became a certified neurologist in 2008. In 2009/2010 he joined a fellowship in Neurological Critical Care and Vascular Neurology at Massachusetts General Hospital, Boston, MA, USA. Since 2010 he has worked as a stroke neurologist at Aarhus University Hospital. He is the principal investigator in Denmark for the EU funded study “WAKE-UP”, being the best recruiting hospital in Europe. Also, he performs the GOLIATH trial at Aarhus University Hospital. He is the author/co-author of 46 papers published in international journals.  

Eivind Berge

Eivind Berge is senior consultant in cardiovascular medicine at Oslo University Hospital and professor at University of Tromsø (Norway). His focus of research is cerebrovascular medicine, and he is Head of the Stroke Research Group at Oslo University Hospital, Ullevål. He is Fellow of the European Stroke Organisation (ESO) and Chair for the ESO Board of Directors, and the ESO Trials Network Committee. He is also Fellow of the Royal College of Physicians in Edinburgh (UK), and member of the editorial board for Stroke, European Stroke Journal, and other journals.

His main interest is randomised-controlled clinical trials in stroke. He was Trial Manager in the Heparin in Acute Embolic Stroke Trial (HAEST) (Lancet 2001), Co-ordinating Investigator in the Scandinavian Candesartan Acute Stroke Trial (SCAST) (Lancet 2011). He was also Norwegian Co-ordinating Investigator in the Third International Stroke Trial (IST-3) (Lancet 2012) and has similar roles in other, on-going academic stroke trials. He is currently Co-ordinating Investigator in the Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST) and Study of Antithrombotic Treatment after IntraCerebral Haemorrhage (STATICH). He is also involved in other types of stroke research, from laboratory research to observational epidemiological studies, Cochrane systematic reviews of effect of interventions, cost-effectiveness studies, and development of clinical guidelines for management of stroke.

Else Charlotte Sandset

Else Charlotte Sandset is a neurologist and postdoctoral fellow at the Department of Neurology, Oslo University Hospital in Norway. She completed her undergraduate medical training at the Royal College of Surgeons in Ireland in 2006, and her PhD from the University of Oslo, Norway in 2012. Her main area of interest is acute stroke, with special emphasis of hemodynamic variables such as blood pressure. She is the chair of the Young Stroke Physicians Committee of the European Stroke Organisation

Grethe Andersen

Professor at Aarhus University and director at Danish Stroke Center at Aarhus University Hopsital 2011. Consultant at Department of Neurology AUH and head of the Stroke Unit 2001- 2011.

Doctor of medical science (DMSc) Aarhus University, Health 1998. The focus of research is “Life after stroke” prospective stroke cohort studies and independent RCT studies. Several studies on acute stroke treatment and organization has been undertaken. The research activities originate from an extensive multidisciplinary and productive network in basic science, clinical epidemiology, neurology and nursing science. Recently an initiative to validate and implement a systematic stroke scoring and registration 2016 in ambulances for future use nationwide has started. Further, collaborators from Danish Stroke Center plan a second neuroprotective multicenter study of perconditioning during ambulance transport. The ambition is also to act as an opinion leader and to participate in several public stroke awareness campaigns and educational initiatives.

Hanne Christensen

Hanne Christensen was MD in 1995, PhD in 2002, and DMSci in 2007 from Copenhagen University.

She was board certified as Neurologist in 2007, and has worked as senior consultant from 2008 in Bispebjerg Hospital, Copenhagen. In 2015 she was appointed full Professor of Neurology with Special Focus on Stroke by Copenhagen University. She has published 94 Medline-indexed papers, 3 text book chapters, and has an H-index of 29; she is supervisor for 9 ongoing or completed PhD-students. She is Chairman of the Danish Stroke Society; and serves European Stroke Organisation (ESO) as Chairman of Council of Fellows as well as member of the Guideline Committee and Women’s Initiative for Stroke in Europe (WISE); she is prior member of ESO’s Board of Directors. Her research is focused on acute stroke.

Hans-Christoph Diener

MD, PhD - Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Hans-Christoph Diener is Senior Professor of Clinical Neurosciences at the Department of Neurology at the University of Duisburg-Essen, Essen Germany. He was Professor of Neurology and Chairman of the Department, Chairman of the Essen Stroke Centre, the Essen Headache Centre and the Vertigo and Dizziness Centre from 1989 to 2016.. He was formerly President of the German Neurological Society (2003–2004) and President of the International Headache Society (2009–2011). Dr. Diener’s special research interests focus on stroke, headache and cerebellar diseases. He has set up the first acute stroke unit in Germany in 1995. He was the principal investigator of major trials in the acute therapy and prevention of stroke (ESPS2, MATCH, PRoFESS). Dr. Diener participated in most major trials on stroke prevention in AFib with new anticoagulants (RE-LY, ROCKET-AF, AVERROES, ARISTOTLE). He is the Co-PI of the RESPECTUS-ESUS trial and chairs the PRODAST registry. He is responsible for VISTA-PREVENTION. Prof. Diener has authored or co-authored 901 articles in peer reviewed journals (182 as first author, 19 in the NEJM), 324 invited reviews, and 342 book chapters, and served as the editor or author of 81 books. His h index is 97. He is the editor of Aktuelle Neurologie, and Arzneimitteltherapie, deputy editor of Cephalalgia and serves on the editorial boards of Lancet Neurology, Cerebrovascular Diseases, and Future Neurology

Helle Klingenberg Iversen

Research associate Professor at University of Copenhagen and Coordinating manager of the stroke center Rigshospitalet, Blegdamsvej and Glostrup. Consultant at Department of Neurology Rigshospitalet and head of the Stroke Unit since 2004.    

Doctor of medical science (DMSc) University of Copenhagen 2004. Vice-chairman of the Danish Stroke Society and chairman of the National Thrombolysis group in Denmark. Focus on clinical and translational research, stroke –subgroups, sleep disturbances in stroke, prospective stroke cohort studies, independent RCT studies, organisation of stroke service and patient and relative communication and involvement. 

Iris Brunner

Associate professor at the University of Aarhus / Hammel Neurocenter in Denmark

Main areas of interest include upper limb motor recovery after stroke, technology-assisted rehabilitation and life after stroke. As a physiotherapist, specialized in neurological physiotherapy, she has been working within neurorehabilitation for many years in acute and rehabilitation settings. During recent years, Iris Brunner was principal investigator for VIRTUES (Virtual reality training for upper extremity in sub-acute stroke) trial. In this multicenter study, VR training was compared to a conventional control intervention. Current projects involve stress reduction in severely impaired patients with disorders of consciousness, the implementation of prediction algorithms for upper limb motor function and enriched environments in neurorehabilitation. Another key interest is knowledge transfer from research to clinical practice, which resulted in the organization of the first Scandinavian Summer School for Neurorehabilitation last year.  

Jens Erik Nielsen-Kudsk

Associate professor, MD, DMSc at Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.

Jens Erik Nielsen-Kudsk is an interventional cardiologist and head of Structural Heart Interventions at Aarhus University Hospital, Skejby, Denmark. He is one of the pioneers in the field of left atrial appendage occlusion (LAAO) that is a novel non-pharmacological method for stroke prevention in atrial fibrillation. He has trained most other LAAO operators in Scandinavia and is one of the primary drivers for Nordic LAAO clinical trials. He has also participated as an interventionalist in the major PFO closure trials in cryptogenic stroke. He has an additional long-standing interest in basic and clinical research in pulmonary hypertension, pulmonary embolism and right heart failure. Jens Erik Nielsen-Kudsk is author of more than 130 scientific publications.

Joung-Ho Rha

DM, PhD

Graduated Seoul National University Medical College in 1987 and finished neurology residency & fellowship at the same hospital. Visiting scholar at UCLA Stroke Center 2001~3. Currently working as professor of neurology and stroke center director of Inha University Hospital at Incheon, Korea. Participated many trials and has been national coordinator of SITS-NEW study. Section director of Korean clinical practice guideline of stroke and chair of Stroke unit certification program in Korea. Also serving as vice president of Korean Stroke Society and national delegate of Korean Neurological Association. Main research interest is thrombolytic and endovascular treatment and stroke care organization.

Joon-Tae Kim

Department of Neurology Chonnam National University Medical School, South Korea 

 

Kate Lykke Lambertsen

MSc from the University of Southern Denmark in 1999

Kate Lykke initiated her training in experimental neurobiology in the Department of Anatomy and Neurobiology, University of Southern Denmark, supervised by dr. Bente Finsen, when she was a master student. Following graduation in 1999 she became a PhD student in experimental neurobiology in the same department. In 2004 she defended her PhD thesis entitled ”The patophysiological role of tumor necrosis factor and interferon gamma in focal cerebral ischemia in mice”. In 2005-2008 she did her first post doc funded by the Danish Medical Research Counsil at the Medical Biotechnology Center, University of Southern Denmark. In 2008-09 she was a visiting scientist at the Miami Project to Cure Paralysis funded by a grant from Carlsbergfondet. Upon her return to Odense, she was appointed an associate professor in Anatomy and Neurobiology at the Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark. In the Lambertsen laboratory they are studying cerebrovascular diseases of and trauma to the central nervous system, such as stroke and spinal cord injury (SCI) to try to understand the cellular and molecular mechanisms that contribute to secondary neuronal cell death. We have primarily one main research objective, which is to study the neuro-inflammatory response that occurs following stroke and SCI with the aim to contribute to the development of novel therapies for stroke and SCI patients. 

Kim Ryun Drasbek

Associate Professor at Center of Functionally Integrative Neuroscience (CFIN), Aarhus University

Kim Ryun Drasbek, MSc in molecular biology obtained his PhD from Aarhus University in 2005 and was appointed associate professor in 2011 at Department of Clinical Medicine, Aarhus University. His research is focused on different approaches to minimize the consequences of stroke using animal models, optical and MR imaging, extracellular vesicle profiling, miRNA sequencing, and bioinformatics. After working extensively on developing a master education in Neuroscience and Neuroimaging in 2010/2011 as part of the Sino-Danish Center for Education and Research (SDC), he was appointed Head of Programme in 2012. In that capacity, he has initiated and organized several international symposia and seminars in China. In 2015, he co-founded the Danish Stroke Researcher Association (DSRA) and organized the first national symposium in June 2016.

Kjell Arne Kvistad

MD PhD is head of neuroradiology at St Olav University Hospital in Trondheim, Norway.

Kjell Arne Kvistad (b. 1960), MD PhD is head of neuroradiology at St Olav University Hospital in Trondheim, Norway. He works as a diagnostic neuroradiologist with a particular interest in MR imaging. He has authored and co-authored more than 50 scientific publications, his main research interest has been imaging in traumatic brain injury, brain tumor imaging, imaging of degenerative spine disease and breast tumor MR imaging.

Kristian Kraglund

MD, PhD-student

Kristian L Kraglund is a PhD-student at the dept. of neurology and earned his MD from Aarhus University in 2011. He is currently besides his research in a specialist training programme in neurology. From 2013 he has worked as the study director of the TALOS (CITAlopram in acute Stroke). This randomised, controlled trial has been completed and is part of his PhD; more than 600 ischemic stroke patients were included in the trial in the early phase after stroke onset. The focus on his research is on serotonin and selective serotonin reuptake inhibitors in strokes. His main interest in this field is especially in the potential effects of SSRI in the vascular system (e.g. platelet-inhibition) and the neuroprotective effects in improving rehabilitation.

Leif Østergaard

Center of Functionally Integrative Neuroscience (CFIN) and Department of Neuroradiology, Aarhus University is interested in the evolution of tissue injury after stroke. 

He works with magnetic resonance imaging (MRI) and optical methods to study tissue hemodynamics and is particularly interested in the microcirculation as a source of neurological symptoms and tissue injury in stroke, small vessel disease, and dementia.

Lise Randrup Jensen

Affiliate researcher at Department of Neurology, Rigshospitalet-Glostrup and Associate professor in logopedics at Department of Nordic Studies and Linguistics, University of Copenhagen

My research interests are in the field of speech language therapy and aphasia with a focus on evidence-based methods of rehabilitation which has potential impact on the field of practice. This includes methods for evaluating language and communication in aphasia and its consequences for the individual and also methods of training and rehabilitation targeting communication or broader psychosocial issues. My current research is on methods of training communication partners of people with aphasia, i.e. methods which target health care professionals or family members and significant others: How may these methods be implemented in clinical field of practice, what are the appropriate outcome measures and how may current training methods be refined or improved.

Marc Fisher

M.D. - Beth Israel Deaconess Medical Center, Boston MA

Dr. Fisher has had a long career as a translational and clinical researcher in the stroke field. He was at the University of Massachusetts Medical School for 36 years, retiring in 2014. While there, he led a stroke modeling lab for 25 years that focused on using MRI technology to evaluate the ischemic penumbra and the effects of many types of therapies on the evolution of ischemic injury. He trained more than 25 research fellows from around the world, many of whom currently hold prestigious positions. He participated in many clinical trials as a principal investigator or steering committee member. Dr. Fisher was also an active clinician and teacher. Currently, Dr. Fisher is a part time member of the neurology faculty at Beth Israel Deaconess Medical Center in Boston and is a Professor of Neurology (part time) at Harvard Medical School. He continues to see patients and teach residents and stroke fellows. He is the Editor-in-Chief of Stroke and will hold that position until 2020.

Mark Treherne

Mark has over 25 years’ experience in the discovery of novel treatments for diseases of the central and peripheral nervous systems, including Parkinson’s and Alzheimer’s diseases.
Mark formerly worked with Pfizer where he was responsible for research into neurodegenerative diseases and, in 1997, set up Cambridge Drug Discovery as Chief Executive, which he sold to BioFocus in 2001. Mark has since worked with many early-stage biotechnology companies and is an author of over 70 articles published in the scientific and trade press. Mark obtained his PhD in receptor neuropharmacology from Cambridge University.

Mathias Gelderblom

M.D. from the Universitaet Kiel, School of Medicine, Kiel, Germany.

As a graduate student he was trained in the laboratory of Professor Steven Waxman, Center for Neuroscience and Regeneration Research, Yale School of Medicine, New Haven, CT, USA. Dr. Gelderblom then started his residency in Neurology at the University Hospital Hamburg Eppendorf, Department of Neurology, Hamburg, Germany. Mathias Gelderblom is currently employed as Clinician Scientist and Clinical Attending at the Department of Neurology, University Medical Center Hamburg-Eppendorf.  

Mayank Goyal

Professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary. Director of Imaging and Endovascular treatment at the Calgary Stroke Program. Medical Director of the Seaman Family MR Research Centre

Dr. Goyal’s passion and main research interest is acute stroke imaging, workflow and intervention. He has over 190 publications in peer-reviewed journals. He is one of the Principal Investigators in two global multi-centric trials in the field: ESCAPE and SWIFT PRIME (both published in NEJM). He was the core-lab for the REVASCAT trial. He is the Co-PI of a CIHR funded study called PROVE IT. Dr. Goyal is world renowned for his ground-breaking work in efficiency and workflow in acute stroke intervention. He was one of the key components that helped the Calgary Stroke Program in becoming one of the best acute stroke programs in the world. He came up with a new way of imaging in acute stroke called multiphase CT angiography. This technique subsequently became the basis for the PROVE IT study and was implemented globally as part of the ESCAPE study. Initial results and feedback suggest that the technique is extremely useful and saves on average 20 minutes in acute stroke treatment. He is also leading a meta-analysis (HERMES) consisting of the recent 5 positive trials published in NEJM. The first paper was recently published in Lancet. The second paper analyzing the impact of time on outcome was recently published in JAMA (Mayank as co-first author). Dr. Goyal continues to push the boundaries of stroke research and is the Co-PI for a new trial called ESCAPE-NA1 (testing the added usefulness of neuroprotection in addition to endovascular stroke therapy). Mayank enjoys teaching and successfully runs a yearly stroke course called 5T (where the 5Ts stand for: teamwork, transport, training, technique and technology).

Mia Ingerslev Loft

Nurse with an MSc in Nursing and is about to finish her Ph.d. She is employed at the department of Neurology, Rigshospitalet Copenhagen.

Her research focuses on patients with stroke and as a part of this, strengthening the nurse’s contribution in stroke rehabilitation. Mia has a special interest in communicating the impact of stroke from the patients’ perspective. Furthermore Mia is dedicated to developing clinical relevant research and decreasing the practice knowledge gap.

Mogens Lytken Larsen

Specialist in cardiology and Professor at Aalborg University

Mogens Lytken Larsen is a specialist in cardiology and Professor at Aalborg University. Professor Larsen’s research interests are preventive cardiology, dyslipidemia, and cardiac rehabilitation. He is a co-author of the major statin trials 4S and IDEAL and has contributed to national as well as international guidelines in this field. Professor Larsen has published more than 100 papers and is associate editor of the Scandinavian Cardiovascular Journal and the past-president of the Danish Society of Cardiology

Mona K Beyer

Professor at Oslo and Akershus University College of Applied Sciences, Oslo, Norway. Neuroradiologist at Oslo University Hospital (The National Hospital). PhD in 2007 from the University of Bergen, Norway. MD in 1995 at the University of Bergen, Norway

I have a PhD on dementia in Parkinson’s disease from 2007. My special interest is in cognitive impairment and dementia, and at the moment I focus a lot on vascular dementia through the NorCOAST study. The aims of the longitudinal Norwegian multicenter NorCOAST study is improved competence on post-stroke dementia (PSD) and other cognitive impairment (MCI), improved diagnostic work-up and treatment and to improve individual health outcomes after stroke. I am strongly involved in the imaging work package of the study where we aim to find associations between imaging markers and the development of cognitive impairment and dementia after stroke. Collaboration between 5 different stroke centers in Norway (Haukeland University hospital Bergen, Ålesund Hospital, Bærum Hospital, Oslo University Hospital, and St Olav University Hospital, Trondheim) has made this study possible. More than 800 acute stroke patients are included at baseline. Currently I supervise one PhD and one masterstudent with data from this project, which started in 2015. I also work with multiple sclerosis research.

Mona K. Aaslund

PhD and specialist in neurophysiotherapy Mona K. Aaslund works as a physiotherapist at the Physiotherapy Department at Haukeland University Hospital and as an associate professor at the Physiotherapy Research group at the University of Bergen.

Mona has done a post doc project were objectively measured physical behaviour, mobility, activities of daily living, life quality, fatigue, depression, sleep and cognition were explored long term after stroke. Mona did her BSc in Physiotherapy at the University of Brighton in 1995-1998 and her MSc in Physiotherapy at the University of Bergen in 2004-2006. In 2012 Mona defended her PhD thesis on “Treadmill walking with body weight support. Clinically she has worked within the field of neurology her whole career and is also currently working in the acute clinical neurological wards and at the Stroke Unit at Haukeland University Hospital.

Natalia S. Rost

MD, MPH, FAAN, FAHA. Director of the Acute Stroke Service at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School

As clinician-scientist, Dr. Rost dedicated her career to care of patients with stroke and reducing the burden of post-stroke disability. She is broadly recognized as an expert in neuroimaging markers of cerebrovascular disease, genetics of stroke, and outcome prediction in patients with acute stroke.  Dr. Rost is PI of the NIH-funded SALVO and MRI-GENIE studies, as well as co-investigator on multiple multidisciplinary, multi-center collaborations involving the NINDS StrokeNET clinical trials network and the International Stroke Genetics Consortium.  Dr. Rost is an author of numerous peer-reviewed publications, book chapters, and a co-author of the “MGH Handbook of Neurology.”   She currently serves as Assistant Editor of STROKE journal and Chair of Science Committee of the American Academy of Neurology.  

Niels Hjort

Niels Hjort is MD and PhD from Aarhus University

He is working as a consultant at the stroke unit at the Department of Neurology at Aarhus University Hospital and is assiciate proressor at The Faculty of Health, Aarhus University. His research focus on acute stroke imaging and treatment. 

Nils Wahlgren

Nils Wahlgren is Professor of Neurology and Head of Stroke Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 
Nils Wahlgren is Chairman of SITS International, including over 1400 stroke centres in 65+ countries using SITS stroke registries and research platforms; founder of Karolinska Stroke Update conferences, now in collaboration with ESO as ESO-Karolinska Stroke Update; co-founding member of European Stroke Conference and co-founding member and Fellow of the European Stroke Organisation (ESO). Nils Wahlgren was the first chairman of the Swedish National Stroke Council. Nils Wahlgren’s research activities are focused on stroke prevention and acute stroke treatment. He has coordinated numerous trials and registries in these areas. He founded the SITS registry which had a key role for implementation of thrombolysis in Europe. Lately, his interest is directed towards blood brain barrier dysfunction as significant pathophysiological mechanism in acute stroke. In 2015, Nils Wahlgren received the Nordic Stroke Award.

Nina Kerting Iversen 

PhD in Animal Physiology from 2012 from Institute of Bioscience, Aarhus University

Nina has been working at the Center of Functionally Integrative Neuroscience, CFIN at the Institute of Clinical Medicine, Aarhus University first as a post doc and later as an Assistant Professor. In addition, she is the daily leader of the Two-Photon Microscopy Pre-clinical Laboratory. Her main research interest is in translational acute ischemic stroke and further how the flow dynamics in the microvasculature affects the oxygen extraction and thereby the survival of the tissue. 

Peter Brynningsen

MD, PhD, specialist in internal medicine and geriatrics.

Works as consultant at Department of Geriatrics in Aarhus University Hospital. Experiences in Stroke treatment and rehabilitation in geriatric patient and early supported discharge services.

Peter Langhorne 

Professor of Stroke Care, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK

Peter Langhorne is Professor of Stroke Care at the University of Glasgow, UK. His research work has focussed on the effectiveness of different treatment strategies for stroke patients, including service delivery (eg. stroke units and early supported discharge) and stroke rehabilitation (eg. early rehabilitation). This work has involved the use of various methodological approaches and collaboration with more than 50 colleagues from around the world. He is the coordinating editor of the Cochrane Stroke Group and is still trying to complete his Munros. 

Philip Bath

FRCP DSc FMedSci, Stroke Association Professor of Stroke and Head of the Division of Clinical Neuroscience at the University of Nottingham, UK, and National Institutes of Health Research Senior Investigator

Philip Bath is a consultant physician in stroke (managing both inpatients and outpatients) and hypertension at Nottingham University Hospitals NHS Trust. He was the Stroke Association’s Keynote Lecturer in 2015, and the International Stroke Conference William M Feinberg Award Lecturer for Excellence in Clinical Stroke in 2016.Prof. Bath’s research interests involve the pathophysiology and management of acute stroke, and prevention of stroke and vascular dementia. His particular interests relate to blood pressure management, haemostasis, stem cell therapy, and treatment of post-stroke dysphagia. He has >340 publications. He was/is Chief Investigator of the TAIST (Lancet 2001), ENOS (Lancet 2015), STEPS (Stroke 2016), PODCAST (PLoSOne 2017), TARDIS and RIGHT-2 multicentre randomised controlled trials. He coordinates international collaborations on acute stroke blood pressure management, and optimising the design and analysis of trials in acute stroke, stroke prevention, and cognition. He also facilitates preclinical studies of stroke interventions.

 

Rikke Sørensen

Cardiologist employed at Copenhagen University Hospital, Rigshospitalet.

At the moment I am attending a training program to become an Interventionalist, doing different procedures as percutaneous coronary interventions. Throughout my career I have had a great interest in antithrombotic medications. I have done epidemiological research on different types of antithrombotic treatment used in patients with myocardial infarction and atrial fibrillation. I hope that the great awareness throughout the last years on both thrombotic risk and bleeding risk related to different treatment regimens, in the end will guide us towards a safe and effective treatment for each individual patient. 

Rolf Blauenfeldt

MD from Aarhus University in 2011

Since 2013 he has been specializing in clinical neurology at Aarhus University Hospital and Aalborg University Hospital. The main focus of his research has been on the neuroprotective effect of prestroke physical activity and remote ischemic conditioning in acute ischemic stroke. From 2018 he will be study director of RESIST trial. RESIST is a multicenter randomised trial investigating whether remote ischemic conditioning (RIC) can improve recovery in acute ischemic stroke patients.  

 

 Sidsel Gaarn Hastrup

 Læge, ph.d.-studerende 

 

Sidsel Hastrup was MD from Aarhus University in 2010. Since 2011 she has been specializing in clinical neurology at Aarhus University Hospital and Aalborg University Hospital. In 2013 she began as a part-time PhD-student beside her clinical work at Aarhus University. Her research studies have focus on organization of stroke services both in the prehospital as well as in-hospital phase. She is a board-member of Danish Stroke Society. 

Søren Paaske Johnsen

Research consultant and associate professor in clinical epidemiology at Aarhus University Hospital and Aarhus University, Denmark.

His primary field of interest is health services research and quality of clinical care including use of evidence-based care, effectiveness and safety of interventions and evaluation of quality improvement strategies. The research involves multiple disease areas, but has a particular focus on stroke. Dr. Johnsen received his medical degree and PhD degree in epidemiology. He has been involved with the Danish Stroke Registry since the late 1990’s and currently leads a research group at Aarhus University Hospital and Aarhus University.   

 Teresa Ullberg 

 MD and PhD at Skåne University hospital in Lund/Malmö

Teresa Ullberg obtained her medical degree from the University of Copenhagen in 2008. She has worked as a neurology resident at Skåne University Hospital since 2010. In 2016, Teresa finished her PhD on post-stroke care and outcomes, and is currently pursuing her postdoc in “Stroke policy and quality register research” at Lund University.

Tomas Deierborg

Associate Professor - Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University
 

Tomas Deierborg is an experimental researcher that early in his career established a model of global brain ischemia in the mouse to study the delayed selective cell death in hippocampus. He has also studied stroke-injured neurogenesis and in 2013 he established his own research group at Lund University in Sweden studying the role of microglial cells in neurodegenerative diseases. He has lately been focusing on a microglial specific protein; the carbohydrate-binding protein galectin-3 that is specifically expressed by highly activated microglial cells. In 2015, the work of his group resulted in the discovery that microglial-derived galectin-3 binds in a paracrine fashion to the key inflammatory receptor TLR4.